Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2011 1
2012 1
2013 1
2015 1
2018 3
2019 2
2020 1
2021 1
2022 4
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Levetiracetam Mechanisms of Action: From Molecules to Systems.
Contreras-García IJ, Cárdenas-Rodríguez N, Romo-Mancillas A, Bandala C, Zamudio SR, Gómez-Manzo S, Hernández-Ochoa B, Mendoza-Torreblanca JG, Pichardo-Macías LA. Contreras-García IJ, et al. Pharmaceuticals (Basel). 2022 Apr 13;15(4):475. doi: 10.3390/ph15040475. Pharmaceuticals (Basel). 2022. PMID: 35455472 Free PMC article. Review.
Antiangiogenic Effect of Dopamine and Dopaminergic Agonists as an Adjuvant Therapeutic Option in the Treatment of Cancer, Endometriosis, and Osteoarthritis.
Mendoza-Torreblanca JG, Cárdenas-Rodríguez N, Carro-Rodríguez J, Contreras-García IJ, Garciadiego-Cázares D, Ortega-Cuellar D, Martínez-López V, Alfaro-Rodríguez A, Evia-Ramírez AN, Ignacio-Mejía I, Vargas-Hernández MA, Bandala C. Mendoza-Torreblanca JG, et al. Int J Mol Sci. 2023 Jun 15;24(12):10199. doi: 10.3390/ijms241210199. Int J Mol Sci. 2023. PMID: 37373348 Free PMC article. Review.
Therapeutic Potential of Dopamine and Related Drugs as Anti-Inflammatories and Antioxidants in Neuronal and Non-Neuronal Pathologies.
Bandala C, Cárdenas-Rodríguez N, Mendoza-Torreblanca JG, Contreras-García IJ, Martínez-López V, Cruz-Hernández TR, Carro-Rodríguez J, Vargas-Hernández MA, Ignacio-Mejía I, Alfaro-Rodriguez A, Lara-Padilla E. Bandala C, et al. Pharmaceutics. 2023 Feb 18;15(2):693. doi: 10.3390/pharmaceutics15020693. Pharmaceutics. 2023. PMID: 36840015 Free PMC article. Review.
Synaptic vesicle protein 2A: basic facts and role in synaptic function.
Mendoza-Torreblanca JG, Vanoye-Carlo A, Phillips-Farfán BV, Carmona-Aparicio L, Gómez-Lira G. Mendoza-Torreblanca JG, et al. Eur J Neurosci. 2013 Dec;38(11):3529-39. doi: 10.1111/ejn.12360. Epub 2013 Sep 16. Eur J Neurosci. 2013. PMID: 24102679 Review.
COVID-19 in G6PD-deficient Patients, Oxidative Stress, and Neuropathology.
Hernández-Ochoa B, Ortega-Cuellar D, González-Valdez A, Cárdenas-Rodríguez N, Mendoza-Torreblanca JG, Contreras-García IJ, Pichardo-Macías LA, Bandala C, Gómez-Manzo S. Hernández-Ochoa B, et al. Curr Top Med Chem. 2022;22(16):1307-1325. doi: 10.2174/1568026622666220516111122. Curr Top Med Chem. 2022. PMID: 35578850
Analysis of Adverse Drug Reactions in Pediatric Patients with Epilepsy: An Intensive Pharmacovigilance Study.
Hernández García E, Naranjo L, Pichardo-Macías LA, Bernad Bernad MJ, Castro-Pastrana LI, Ruíz García M, García Bernal TA, Mendoza Solís JL, Calderón Guzmán D, Díaz-García L, Mendoza-Torreblanca JG, Chávez Pacheco JL. Hernández García E, et al. Children (Basel). 2023 Nov 1;10(11):1775. doi: 10.3390/children10111775. Children (Basel). 2023. PMID: 38002866 Free PMC article.
Evaluation of the Antioxidant Activity of Levetiracetam in a Temporal Lobe Epilepsy Model.
Ignacio-Mejía I, Contreras-García IJ, Mendoza-Torreblanca JG, Medina-Campos ON, Pedraza-Chaverri J, García-Cruz ME, Romo-Mancillas A, Gómez-Manzo S, Bandala C, Sánchez-Mendoza ME, Pichardo-Macías LA, Cárdenas-Rodríguez N. Ignacio-Mejía I, et al. Biomedicines. 2023 Mar 10;11(3):848. doi: 10.3390/biomedicines11030848. Biomedicines. 2023. PMID: 36979827 Free PMC article.
21 results